Table 1

Description of included studies in the systematic review

Authors	Name of questionnaire	Psychometric evaluation(s)	Time of administration	Target population	Study population	Mode of administration
Kirmit et al57	AAOS-HS	Inter-tester reliability	Preop.	Hip OA	N=35 (IA)	Observer-administered
					18♀, 17♂
					Mean (SD) 58.8 (2.2) y
					Range (28–76 y)
Martin et al38	HOS	Content validity	Clinical visit/Postop.	Labral tear/hip arthroscopy	N=507 (IA)	Self-administered
		Internal consistency			273♀, 232♂
		Construct validity			Mean (SD) 38 (13) y
					Range (13–66 y)
Martin et al42	HOS	Construct validity	Postop.	Hip arthroscopy	N=107 (IA)	Self-administered
					56♀, 51♂
					Mean (SD) 42 (14) y
					Range (14–79) y
Martin et al52	HOS	Test–retest reliability	Preop./Postop.	Hip arthroscopy	N=126 (IA)	Self-administered
		Responsiveness			59♀, 67♂
					Mean (SD) 41 (16) y
					Range (13–80) y
Klassbo et al35	HOOS	Content validity	Clinical visit	Hip OA	N=52 (IA)	Self-administered
		Internal consistency			35♀, 17♂
		Construct validity			Median 64 y
		Floor and ceiling effects			Range (42–84 y)
		Test–retest reliability
		Agreement
Nilsdotter et al41	HOOS	Content validity	Preop./Postop.	THR	N=90 (ES)	Self-administered
		Internal consistency			41♀, 49♂
		Construct validity			Mean 71.5 y
		Floor and ceiling effects			Range (49–85 y)
		Responsiveness
		Interpretability
de Groot et al43	HOOS	Internal consistency	Clinical visit/Postop.	Hip OA/THR	N=162 (IA)	Self-administered
		Construct validity			Range (31–88 y)
		Floor and ceiling effects
		Test–retest reliability
		Agreement
		Responsiveness
		Interpretability
Johanson et al53	HRQ	Internal consistency	Preop./Postop.	THR	N=98 (ES)	Self-administered
		Construct validity	Follow-up: 3, 6, 12 months		61♀, 37♂
		Test–retest reliability			Mean (SD) 65 (10) y
		Agreement			Range (21–90) y
		Responsiveness			3 months N=98
		Interpretability			6 months N=62
					12 months N=42
Franneby et al76	IPQ	Internal consistency	Postop.	Open groin-hernia repair	N=200 (IA)	Self-administered
		Construct validity			5%♀, 95%♂
		Test–retest reliability			Mean (SD) 63 (14) y
Lequesne et al77	LISH	Inter-tester reliability	During clinical trial	Hip OA	N=38 (ES)	Observer-administered
Stucki et al32	LISH	Internal consistency	Clinical visit	Hip OA	N=22 (ES)	Self-administered
		Construct validity
		Test–retest
		Interpretability
Stucki et al33^*	LISH	Internal consistency	Clinical visit	Hip OA	N=22 (ES)	Self-administered
		Construct validity
Ludwig et al44	LISH	Internal consistency	Preop./Postop.	THR	N=112 (ES)	Self-administered
		Construct validity			39♀, 73♂
		Test–retest reliability
		Responsiveness
Dawson et al40	LISH	Content validity	Baseline	Unilateral hip pain	N=471 (IA)	Self-administered
		Internal consistency	Follow-up: 12 month		60.5%♀, 39.5%♂
		Construct validity			Range (68–79 y)
Potter et al45	MHHS	Construct validity	Postop.	Hip arthroscopy	N=33 (IA)	Observer-administered
		Interpretability	Mean follow-up: 25.7 months		19♀, 14♂
					Mean 34.6 y
					Range (21–56) y
Christensen et al36	NHS	Content validity	Clinical visit	Hip pain for 6 months, no signs of radiographic OA	N=48 (IA)	Self-administered
		Internal consistency			29♀, 19♂
		Construct validity			Mean 33 y
		Test–retest reliability			Range (16–45 y)
Dawson et al29	OHS	Content validity	Preop./Postop.	THR	N=220 (ES)
		Internal consistency			131♀, 89♂
		Construct validity			Median 70.5 y
		Test–retest reliability			Range (35.8–89.6 y)
		Responsiveness
		Interpretability
Dawson et al30	OHS	Responsiveness	Preop./Postop.	THR	N=186 (IA)
		Interpretability	Follow-up: 6 months		117♀, 69♂
					Median 70.5 y
					Mean (SD) 69.4 (3.5) y
					Range (37.5–89.6 y)
Fitzpatrick et al31	OHS	Responsiveness	Preop./Postop.	THR	N=186 (IA)
		Interpretability			63%♀, 37%♂
					Median age 70.5 y
					Mean (SD) 69.4 (3.5) y
					Range (37.5–89.6 y)
Fitzpatrick et al78	OHS	Internal consistency	Preop./Postop.	THR	N=7151 (ES)
		Responsiveness	Follow-up: 3 and 12 months		61.4%♀, 38.6%♂
		Interpretability			Mean (SD) 67.8 (10.9) y
					3 months N=6174
					12 months N=5854
Dawson et al79	OHS	Construct validity	Preop./Postop.	THR	N=609 (ES)
		Responsiveness	Follow-up: 1 y
		Interpretability
Ostendorf et al48^*	OHS	Responsiveness	Preop./Postop.	THR	N=114 (IA)
		Construct validity	Follow-up: 3 months, 1 y		62.3%♀, 37.7%♂
		Floor and ceiling effect			Mean (SD) 67.6 (10.1) y
		Interpretability			Range (35.9–88.8 y)
Gosens et al54	OHS	Content validity	Preop./Postop.	THR	N=150 (ES)	Self-administered
		Internal consistency			98♀, 52♂
		Construct validity			Mean 65 y
		Test–retest reliability			Range (38–85 y)
		Responsiveness
		Interpretability
Garbuz et al49^*	OHS	Construct validity	Preop./Postop.	THR	N=402 (IA)	Self-administered
		Floor and ceiling effects	Follow-up: 12 months		53%♀, 47%♂
		Responsiveness			Mean 61 y
Naal et al46	OHS	Internal consistency	Preop.	THR	N=105 (IA)	Self-administered
		Construct validity			48♀, 57♂
		Floor and ceiling effect			Mean (SD) 63.4 (11) y
		Test–retest reliability			Range (33–88 y)
		Agreement
Wright et al37	PASI	Content validity	Preop.	THR	N=72 (IA)	Observer-administered
					49%♀, 51%♂
					Mean (SD) 64 (7) y
					Range(17–92 y)
Wright and Young27	PASI	Construct validity	Preop./Postop.	THR	N=78 (IA)	Observer-administered
		Test–retest reliability	Follow-up: 6 months		45%♀, 55%♂
		Inter-tester reliability			Mean 62.2 y
		Responsiveness			Range (25–87 y)
		Interpretability
Wright and Young28^*	PASI	Construct validity	Preop./Postop.	THR	N=78 (IA)	Observer-administered
		Test–retest reliability			45%♀, 55%♂
		Inter-tester reliability			Mean 62.2 y
		Responsiveness			Range (25–87 y)
Wright et al55	PASI	Construct validity	Preop./Postop.	THR	N=55 (IA)	Self-administered
		Test–retest reliability			58%♀, 42%♂
					Mean 65.6 y
					Range (28–84 y)
Whitehouse et al80	R-WOMAC-FS	Internal consistency	Postop.	THR	N=716 (ES)	Self-administered
		Construct validity	Follow-up: 36 months		Mean (SD) 73.6 (5.5) y
					Range (65–93 y)
					36 months N=665
Liang et al39^† and Katz et al81	THAOQ	Content validity^*	Preop./Postop.	THR	N=54 (IA)	Self-administered
		Construct validity			36♀, 18♂
		Test–retest reliability			Mean (SD) 60 (13) y
					Range (25–82 y)
Stucki et al34	WOMAC	Construct validity	Clinical visit	Hip OA	N=22 (ES)	Self-administered
Wright and Young28^*	WOMAC	Construct validity	Preop./Postop.	THR	N=78 (IA)	Observer-administered
		Test–retest reliability	Follow-up: 6 months		45%♀, 55%♂
		Inter-tester reliability			Mean 62.2 y
		Responsiveness			Range (25–87 y)
		Interpretability
Stucki et al33^*	WOMAC	Internal consistency	Clinical visit	Hip OA	N=22 (ES)	Self-administered
		Construct validity
Söderman and Malchau50	WOMAC	Internal concistency	Postop.	THR	N=58 (IA)	Self-administered
		Construct validity	Follow-up: 2–10 y		38♀, 20♂
		Floor and ceiling effect			Mean 71 y
		Test–retest reliability			Range (52–86 y)
		Interpretability
Angst et al82	WOMAC	Responsiveness	Pre-/post treatment.	Hip OA	N=93 (IA)	Self-administered
			3–4 weeks rehabilitation		66%♀, 34%♂
			Follow-up: 3 months
Nilsdotter et al83	WOMAC	Responsiveness	Postop.	THR	N=20 (IA)	Self-administered
			Follow-up: 3, 6 and 12 months		13♀, 7♂
					Mean 72.6 y
					Range (52–86) y
Escobar et al84	WOMAC	Responsiveness	Preop./Postop.	THR	N=100 (IA)	Self-administered
		Interpretability			56♀, 44♂
					Mean (SD) 68.6 (10.3) y
Ostendorf et al48^*	WOMAC	Responsiveness	Preop./Postop.	THR	N=114 (IA)	Self-administered
		Construct validity	Follow-up: 3 months, 1 y		62.3%♀, 37.7%♂
		Floor and ceiling effect			Mean (SD) 67.6 (10.1) y
		Interpretability			Range (35.9–88.8 y)
Roorda et al47	WOMAC	Internal consistency	Preop.	THR	N=180 (IA)	Self-administered
		Construct validity			65%♀, 35%♂
		Test–retest reliability			Mean (SD) 67.9 (10.7) y
		Interpretability
Quintana et al51	WOMAC	Internal consistency	Preop./Postop.	THR	6 month: N=379 (IA)	Self-administered
		Floor and ceiling effect	Follow-up: 6 months, 2 y		2 years: N=310 (IA)
		Agreement
		Responsiveness
		Interpretability
Garbuz et al49^*	WOMAC	Construct validity	Preop./Postop.	THR	N=402 (IA)	Self-administered
		Floor and ceiling effects	Follow-up: 12 months		53%♀, 47%♂
		Responsiveness			Mean 61 y
SooHoo et al⁸⁵	WOMAC	Responsiveness	Preop./Postop.	THR	N=89 (ES)	Self-administered
		Interpretability	Follow-up: 5–43 months		54%♀, 46%♂
					Mean 60 y
					Range (20–91 y)
Soininen et al56	WOMAC	Construct validity	Preop. /postop.	THR	N=33 (ES)	Self-administered
		Test–retest reliability	Follow-up: 3 months
		Agreement
		Responsiveness
		Interpretability

↵* Studies evaluating two questionnaires.
↵† Evaluating content validity of THAOQ including experts but not including any patients.
♀, female; ♂, male; AAOS-HS, American Academy of Orthopaedic Surgeons Hip Score; ES, enrolled in the study; HOOS, Hip dysfunction and Osteoarthritis Outcome Score; HOS, Hip Outcome Score; HRQ, Hip Rating Questionnaire; IA, included in the analysis; IPQ, Inguinal Pain Questionnaire; LISH, Lequesne Index of Severity for Osteoarthritis of the Hip; MHHS, Modified Harris Hip Score; NHS, Nonarthritic Hip Score; OA, osteoarthritis; OHS, Oxford Hip Score; PASI, Patient Specific Index; Preop., preoperative; Postop, postopertaive; R-WOMAC-FS, Reduced Western Ontario and McMaster Universities Osteoarthritis index Function Score; THAOQ, Total Hip Arthroplasty Outcome Questionnaire; THR, total hip replacement; y, years.